GlassScriptPhysician profile
Alex Michael Sabers
NPI 1548557374
$15,302.82
in general payments reported to CMS, 2019-2025
37 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $795 · 2021: $469 · 2022: $9,912 · 2023: $2,292 · 2024: $718 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397 · Acquisitions: $1,251 · Travel and Lodging: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.61 |
| Acquisitions | $1,250.54 |
| Travel and Lodging | $1,117.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $11,882.80 | 2022-2024 | Avenger Radial Head, +4 Stems, Colink Plating System, Biobrace 23mm |
| Organogenesis INC. | $882.23 | 2019-2025 | Puraply Wound Matrix, Affinity |
| Surgenex LLC | $301.13 | 2025 | Surgraft, Ardeograft, Pellograft |
| Stryker Corporation | $296.44 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $210.57 | 2020-2024 | Tapestry |
| Integra Lifesciences Corporation | $157.59 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $151.84 | 2021 | |
| Trice Medical, INC. | $137.91 | 2022-2025 | |
| Convatec INC. | $121.55 | 2024 | |
| Wright Medical Technology, INC. | $91.07 | 2019-2020 | |
| Horizon Therapeutics Plc | $89.44 | 2019-2023 | Krystexxa |
| In2bones USA, LLC | $85.36 | 2020 | |
| Acera Surgical, INC. | $65.67 | 2020-2022 | |
| Depuy Synthes Sales INC. | $65.25 | 2022-2025 | Motoband, Minibunion, Motoband Cp |
| Kerecis Limited | $64.68 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $61.55 | 2025 | Stimulan |
| Bioventus LLC | $55.97 | 2019-2025 | Xcell |
| Biowound Solutions, INC. | $52.65 | 2024-2025 | Bio-Connekt |
| Smith+Nephew, INC. | $49.81 | 2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Vertex Pharmaceuticals Incorporated | $45.13 | 2025 | |
| Melinta Therapeutics, LLC | $44.60 | 2022 | |
| Medtronic, INC. | $43.56 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $42.62 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.66 | 2022 | |
| Heron Therapeutics, INC. | $35.28 | 2021-2022 | |
| Abbvie INC. | $34.37 | 2021-2023 | Dalvance |
| Acumed LLC | $31.87 | 2025 | Acumed |
| Globus Medical, INC. | $25.35 | 2025 | Senza |
| Averitas Pharma INC. | $24.67 | 2023 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $22.56 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.28 | 2020 | |
| Osiris Therapeutics INC. | $14.86 | 2019 | |
| Novastep INC. | $14.68 | 2022 | |
| Baudax Bio INC. | $12.54 | 2021 | |
| Allergan, INC. | $11.54 | 2020 | |
| Merck Sharp & Dohme LLC | $10.96 | 2019 | |
| Advanced Oxygen Therapy INC. | $7.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Sabers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.